The new OS results came from the Phase III INAVO120 study evaluating an Itovebi ...
The NICE has issued final draft guidance endorsing the use of CSL Vifor's Filspa...
The Trump administration’s budget reconciliation bill has passed the US House of...
An EMA committee has issued a positive opinion for a label extension that would ...
GSK has received approval from the US Food and Drug Administration (FDA) for its...
BioNTech has entered a grant agreement with the UK government to expand its rese...
Orionis Biosciences has announced a multi-year partnership with Roche’s Genentec...
After the FDA asked for more clinical data in May 2025, Moderna has decided to r...
Potential US pharma import tariffs could raise prices, stifle innovation, and re...
Viz.ai is set to enter into a multi-year collaboration with Sanofi and Regeneron...
We learn how the EU’s new Clinical Trial Regulation (CTR) and the CTIS platform ...
GSK will incorporate the findings into messaging that depemokimab patients will ...
Despite the boost to contributions, WHO has downsized its 2026-27 budget by over...
To overcome pharma logistics challenges with transporting an MS vaccine, an expe...
